Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$307M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$294M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$246M |
| 4 |
Costco
COST
|
+$225M |
| 5 |
Lyft
LYFT
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferguson
FERG
|
+$692M |
| 2 |
Linde
LIN
|
+$624M |
| 3 |
Medtronic
MDT
|
+$527M |
| 4 |
Goldman Sachs
GS
|
+$340M |
| 5 |
Microsoft
MSFT
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.25% |
| 2 | Healthcare | 13.3% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Communication Services | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
The Joint Corp
JYNT
$120M
| $10.7M | ﹤0.01% |
127,387
+43,604
| +52% | +$2.7M |
|
2102
Descartes Systems
DSGX
$6.62B
| $10.7M | ﹤0.01% |
154,330
+46,596
| +43% | +$2.95M |
|
2103
Academy Sports + Outdoors
ASO
$2.98B
| $10.7M | ﹤0.01% |
258,776
+174,323
| +206% | +$6.11M |
|
|
FOLD
2104
DELISTED
Amicus Therapeutics
FOLD
| $10.6M | ﹤0.01% |
1,103,592
+56,428
| +5% | +$551K |
|
2105
Warner Music
WMG
$13.4B
| $10.6M | ﹤0.01% |
294,894
+19,169
| +7% | +$687K |
|
|
AHRT
2106
AH Realty Trust
AHRT
$506M
| $10.6M | ﹤0.01% |
799,349
-20,595
| -3% | -$276K |
|
2107
Ironwood Pharmaceuticals
IRWD
$712M
| $10.5M | ﹤0.01% |
819,452
-176,378
| -18% | -$2.02M |
|
2108
ASE Group
ASX
$103B
| $10.5M | ﹤0.01% |
+1,308,267
| New | +$10.5M |
|
2109
Interface
TILE
$2.19B
| $10.5M | ﹤0.01% |
688,174
-26,872
| -4% | -$387K |
|
|
VIVO
2110
DELISTED
Meridian Bioscience Inc
VIVO
| $10.5M | ﹤0.01% |
474,633
-26,273
| -5% | -$557K |
|
|
AAN
2111
DELISTED
The Aaron's Company Inc
AAN
| $10.5M | ﹤0.01% |
328,489
-25,756
| -7% | -$812K |
|
2112
OceanFirst Financial
OCFC
$1.91B
| $10.5M | ﹤0.01% |
504,119
-24,452
| -5% | -$547K |
|
2113
Inogen
INGN
$153M
| $10.5M | ﹤0.01% |
161,100
-21,883
| -12% | -$1.39M |
|
|
INN
2114
Summit Hotel Properties
INN
$651M
| $10.5M | ﹤0.01% |
1,122,912
-29,121
| -3% | -$288K |
|
2115
Quanex
NX
$962M
| $10.5M | ﹤0.01% |
421,504
-21,965
| -5% | -$586K |
|
2116
StoneX
SNEX
$8.09B
| $10.4M | ﹤0.01% |
871,540
-46,524
| -5% | -$601K |
|
2117
Resources Connection
RGP
$145M
| $10.4M | ﹤0.01% |
725,212
+63,498
| +10% | +$917K |
|
2118
DNOW Inc
DNOW
$2.97B
| $10.4M | ﹤0.01% |
1,095,232
-34,130
| -3% | -$352K |
|
|
TVTY
2119
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $10.3M | ﹤0.01% |
392,632
-43,723
| -10% | -$1.1M |
|
2120
SunCoke Energy
SXC
$794M
| $10.3M | ﹤0.01% |
1,443,740
-38,680
| -3% | -$275K |
|
|
SPWR
2121
DELISTED
SunPower Corporation Common Stock
SPWR
| $10.3M | ﹤0.01% |
351,002
-16,149
| -4% | -$417K |
|
2122
Designer Brands
DBI
$299M
| $10.2M | ﹤0.01% |
618,852
-96,507
| -13% | -$1.7M |
|
2123
Kelly Services Class A
KELYA
$558M
| $10.2M | ﹤0.01% |
427,020
+12,315
| +3% | +$304K |
|
|
NFBK
2124
DELISTED
Northfield Bancorp
NFBK
| $10.2M | ﹤0.01% |
624,139
-23,688
| -4% | -$390K |
|
|
CGC
2125
Canopy Growth
CGC
$431M
| $10.2M | ﹤0.01% |
42,313
+18,374
| +77% | +$4.7M |
|
Similar funds
Bank of New York Mellon's Q2 2021 Portfolio in Review
As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
- Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
- Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
- Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
- Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
- Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.
Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.